Planned sale of 43,920 NOVT (NASDAQ: NOVT) shares under Rule 144

Rhea-AI Filing Summary

The holder of NOVT common stock has filed a Rule 144 notice to sell 43,920 shares. The planned sale is to be executed through J.P. Morgan Securities LLC on Nasdaq, with an approximate sale date of 01/21/2026. The filing shows these shares were acquired through a mix of stock option exercise on 01/21/2026 and multiple compensation awards from the issuer between 2021 and 2024. The number of shares of the same class outstanding is listed as 35,775,123; this is a baseline figure, not the amount being sold.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	J.P. Morgan Securities LLC 270 Park Avenue 10th Floor New York NY 10017	43920	5757912	35775123	01/21/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/21/2026	Stock Option Exercise	Issuer			12803	01/21/2026	Cash
Common	01/01/2022	Compensation award	Issuer			4494	01/01/2022	Compensation
Common	01/02/2024	Compensation award	Issuer			4603	01/02/2024	Compensation
Common	02/21/2023	Compensation award	Issuer			1006	02/21/2023	Compensation
Common	02/26/2024	Compensation award	Issuer			260	02/26/2024	Compensation
Common	02/24/2023	Compensation award	Issuer			4026	02/24/2023	Compensation
Common	02/28/2021	Compensation award	Issuer			16728	02/28/2021	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the NOVT Form 144 filing disclose?

The Form 144 filing discloses that a holder of NOVT common stock plans to sell 43,920 shares of the issuer’s common stock under Rule 144.

How many NOVT shares are planned to be sold and through which broker?

The notice covers a planned sale of 43,920 NOVT common shares through J.P. Morgan Securities LLC.

On which exchange are the NOVT shares expected to be sold and when?

The filing lists Nasdaq as the securities exchange, with an approximate sale date of 01/21/2026.

How were the NOVT shares in the Form 144 acquired?

The shares were acquired via a stock option exercise on 01/21/2026 and several compensation awards from the issuer dated between 02/28/2021 and 02/26/2024.

How many NOVT shares are listed as outstanding in the filing?

The Form 144 lists 35,775,123 shares of NOVT common stock as the number of shares or other units outstanding.

What is the aggregate market value of the NOVT shares to be sold?

The filing states an aggregate market value of 5,757,912 for the 43,920 NOVT common shares covered by the notice.

Does the NOVT Form 144 mention Rule 10b5-1 plans?

The form includes a section to report the date of plan adoption or trading instruction if relying on Rule 10b5-1, along with a representation about not knowing undisclosed material adverse information.